Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1016

1.

Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?

Moncrieff MD, Martin R, O'Brien CJ, Shannon KF, Clark JR, Gao K, McCarthy WM, Thompson JF.

Ann Surg Oncol. 2008 Nov;15(11):3022-7. doi: 10.1245/s10434-008-0087-8. Epub 2008 Oct 30.

PMID:
18958539
2.

Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.

Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Jia C, Kraybill WG.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):467-74.

PMID:
10661355
3.

Adjuvant irradiation for axillary metastases from malignant melanoma.

Ballo MT, Strom EA, Zagars GK, Bedikian AY, Prieto VG, Mansfield PF, Lee JE, Gershenwald JE, Ross MI.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):964-72.

PMID:
11958890
4.

The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.

Agrawal S, Kane JM 3rd, Guadagnolo BA, Kraybill WG, Ballo MT.

Cancer. 2009 Dec 15;115(24):5836-44. doi: 10.1002/cncr.24627.

5.

A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.

Ballo MT, Zagars GK, Gershenwald JE, Lee JE, Mansfield PF, Kim KB, Camacho LH, Hwu P, Ross MI.

Ann Surg Oncol. 2004 Dec;11(12):1079-84.

PMID:
15576833
6.

Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.

Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.

Ann Surg Oncol. 2007 Dec;14(12):3566-74. Epub 2007 Oct 9.

PMID:
17924169
7.

Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas?

Fuhrmann D, Lippold A, Borrosch F, Ellwanger U, Garbe C, Suter L.

Br J Dermatol. 2001 Jan;144(1):66-70.

PMID:
11167684
8.

Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy.

Hamming-Vrieze O, Balm AJ, Heemsbergen WD, Hooft van Huysduynen T, Rasch CR.

Arch Otolaryngol Head Neck Surg. 2009 Aug;135(8):795-800. doi: 10.1001/archoto.2009.80.

PMID:
19687401
9.

Adjuvant irradiation for cervical lymph node metastases from melanoma.

Ballo MT, Bonnen MD, Garden AS, Myers JN, Gershenwald JE, Zagars GK, Schechter NR, Morrison WH, Ross MI, Kian Ang K.

Cancer. 2003 Apr 1;97(7):1789-96.

10.

Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?

Shen P, Wanek LA, Morton DL.

Ann Surg Oncol. 2000 Sep;7(8):554-9; discussion 560-1.

PMID:
11005552
11.

Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.

White RR, Stanley WE, Johnson JL, Tyler DS, Seigler HF.

Ann Surg. 2002 Jun;235(6):879-87.

12.

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Ann Surg Oncol. 2006 Dec;13(12):1655-63. Epub 2006 Oct 3.

PMID:
17016755
13.

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.

Burmeister BH, Henderson MA, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S, Coventry BJ, Babington S, Duprat J, Hoekstra HJ, Thompson JF.

Lancet Oncol. 2012 Jun;13(6):589-97. doi: 10.1016/S1470-2045(12)70138-9. Epub 2012 May 9.

PMID:
22575589
15.

Risk factors for nodal recurrence after lymphadenectomy for melanoma.

Pidhorecky I, Lee RJ, Proulx G, Kollmorgen DR, Jia C, Driscoll DL, Kraybill WG, Gibbs JF.

Ann Surg Oncol. 2001 Mar;8(2):109-15.

PMID:
11258774
16.

Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement.

Veenstra HJ, van der Ploeg IM, Wouters MW, Kroon BB, Nieweg OE.

Ann Surg Oncol. 2010 Feb;17(2):521-6. doi: 10.1245/s10434-009-0776-y. Epub 2009 Nov 7.

PMID:
19898903
17.

The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.

Jakub JW, Huebner M, Shivers S, Nobo C, Puleo C, Harmsen WS, Reintgen DS.

Ann Surg Oncol. 2009 Aug;16(8):2245-51. doi: 10.1245/s10434-009-0530-5. Epub 2009 Jun 11.

PMID:
19517194
18.

Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma.

Conill C, Valduvieco I, Domingo-Domènech J, Arguis P, Vidal-Sicart S, Vilalta A.

Clin Transl Oncol. 2009 Oct;11(10):688-93.

PMID:
19828412
19.

The management of cervical lymph nodes in patients with cutaneous melanoma.

Martin RC, Shannon KF, Quinn MJ, Saw RP, Spillane AJ, Stretch JR, Colman MH, Gao K, Thompson JF.

Ann Surg Oncol. 2012 Nov;19(12):3926-32. doi: 10.1245/s10434-012-2374-7. Epub 2012 Jun 6.

PMID:
22669449
20.

Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?

Ballo MT, Garden AS, Myers JN, Lee JE, Diaz EM Jr, Sturgis EM, Morrison WH, Gershenwald JE, Ross MI, Weber RS, Ang KK.

Head Neck. 2005 Aug;27(8):718-21.

PMID:
15952196
Items per page

Supplemental Content

Write to the Help Desk